Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
The latest announcement is out from ConvaTec ( (GB:CTEC) ).
ConvaTec Group PLC has announced a change in its voting rights structure following an acquisition or disposal of voting rights by FMR LLC, a company based in Boston, USA. As of April 25, 2025, FMR LLC holds 5.065% of the voting rights in ConvaTec, amounting to 103,822,184 shares. This change in voting rights could potentially impact ConvaTec’s governance and decision-making processes, influencing its strategic direction and stakeholder interests.
Spark’s Take on GB:CTEC Stock
According to Spark, TipRanks’ AI Analyst, GB:CTEC is a Outperform.
ConvaTec’s strong financial performance and positive corporate events drive a solid stock score. The company shows robust revenue growth, efficient cash flow management, and strategic innovation focus. However, a high P/E ratio suggests potential overvaluation, slightly impacting the overall score. Stable technical momentum and a positive sales outlook further reinforce confidence in the stock.
To see Spark’s full report on GB:CTEC stock, click here.
More about ConvaTec
ConvaTec Group PLC is a UK-based company operating in the medical products and technologies industry. It primarily focuses on providing solutions for advanced wound care, ostomy care, continence and critical care, and infusion care, catering to healthcare professionals and patients worldwide.
YTD Price Performance: 17.39%
Average Trading Volume: 6,455,624
Technical Sentiment Signal: Strong Sell
Current Market Cap: £5.23B
For a thorough assessment of CTEC stock, go to TipRanks’ Stock Analysis page.